What are the side effects of baricitinib? Common side effects and countermeasures during use

Baricitinib (Baricitinib) is a Janus kinase inhibitor (JAKinhibitor), primarily used to treat moderately to severely active rheumatoid arthritis (RA) in adults. By inhibiting the JAK enzyme, it prevents the immune system from overreacting and reduces inflammation, thereby reducing joint damage. However, like other immunomodulatory drugs, baricitinib may cause some side effects. Understanding these side effects and what to do about them is critical to patient safety.

1. Common side effects

Increased risk of infection: By suppressing the function of the immune system, baricitinib may lead to an increased risk of bacterial, fungal, viral and other infections. In particular, respiratory infections, urinary tract infections, and tuberculosis require special attention. Patients should have their blood levels checked regularly while taking the medication to ensure there are no signs of potential infection.

Gastrointestinal discomfort: Common gastrointestinal side effects include nausea, vomiting, diarrhea, and decreased appetite. These symptoms are usually mild and resolve as the patient adjusts to the medication. For these symptoms, patients can alleviate these symptoms by dividing meals and avoiding greasy foods. If necessary, the taking time of the drug can be adjusted.

Abnormal liver function: Baricitinib may cause an increase in liver enzymes (such as AST, ALT), and long-term use may have certain effects on the liver. Patients need to regularly monitor liver function when using baricitinib. If abnormal liver function indicators are found, they should report to the doctor in time and take corresponding measures.

Increased blood lipids: Baricitinib may cause dyslipidemia, such as increased cholesterol and triglyceride levels. These changes are usually more obvious at the beginning of taking the medication, but most patients' blood lipid levels will stabilize after long-term use. For patients with a history of hyperlipidemia, they may need to take lipid-lowering drugs under the guidance of a doctor.

2. Serious side effects and countermeasures

Hematologic abnormalities: Baricitinib may cause hematologic abnormalities such as leukopenia (low white blood cells), thrombocytopenia, or anemia. A reduced number of white blood cells may make patients more susceptible to infection. Therefore, patients need to have regular blood tests so that blood abnormalities can be detected early and treated accordingly.

Cardiovascular issues: Studies have shown that baricitinib is associated with a risk of cardiovascular events, particularly in patients with preexisting cardiovascular disease. Common cardiovascular side effects include hypertension, heart failure, etc. While taking the medication, patients should regularly monitor their blood pressure, maintain a healthy lifestyle, and report any cardiovascular symptoms, such as chest pain, shortness of breath, etc.

Malignancy: Use of baricitinib may increase the risk of certain malignancies, particularly lymphoma and skin cancer. Patients need to undergo regular physical examinations, including skin examinations, while taking the medication, and pay close attention to any abnormal signs, such as suspicious skin lesions, lumps, etc. If abnormal symptoms occur, patients should seek medical treatment promptly.

3. How to deal with side effects

Patients should follow the doctor's guidance when taking baricitinib and conduct necessary examinations regularly, including routine blood tests, liver function, kidney function, blood lipid levels, etc., in order to detect side effects and take measures in a timely manner. Gastrointestinal discomfort can be relieved by changing eating habits and increasing dietary fiber. If the gastrointestinal discomfort is severe, the doctor may adjust the dosage of the drug or recommend other treatment options based on the patient's specific condition.

When faced with the risk of infection caused by immunosuppression, patients should take preventive measures, such as avoiding contact with people with infectious diseases, and maintaining good personal hygiene habits, such as washing hands frequently and avoiding crowded places. If symptoms of infection occur, seek medical attention immediately and inform your doctor that you are using baricitinib.

For abnormalities in the blood system, patients need to undergo routine blood tests regularly. If abnormalities in white blood cells or platelets are found, the doctor may adjust the treatment plan or suspend the medication. For cardiovascular problems, patients should maintain a healthy lifestyle, such as controlling weight, eating a light diet, increasing exercise, and following the doctor's recommendations.

Baricitinib is an effective drug for the treatment of rheumatoid arthritis, but its use may be associated with some side effects. Through regular monitoring and health management, patients can reduce the risk of side effects while ensuring efficacy. It is important that patients keep in close contact with their doctors and promptly report any symptoms of discomfort to avoid worsening of the condition due to side effects. Following the doctor's medication instructions and taking appropriate preventive and response measures are the keys to ensuring smooth treatment and ensuring patient safety.

Reference materials:https://www.mims.com/hongkong/drug/info/baricitinib?mtype=generic